Bionet (1784) — Cash Flow Reinvestment Rate
Bionet (1784) has a Cash Flow Reinvestment Rate of 3.28x as of December 2025, reinvesting NT$93.46 Million (capex NT$38.02 Million plus investments NT$55.44 Million) from operating cash flow of NT$28.46 Million. Explore 1784 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bionet Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Bionet across 7 annual periods. Also explore Bionet balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bionet (2019–2025)
Year-by-year capital reinvestment analysis for Bionet. For live market cap and broader valuation context, see Bionet (1784) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.04x | NT$302.51 Million | NT$148.04 Million | NT$132.18 Million | ▼ -53.3% |
| 2024 | 4.38x | NT$772.28 Million | NT$176.49 Million | NT$103.49 Million | ▲ +53.6% |
| 2023 | 2.85x | NT$436.21 Million | NT$153.09 Million | NT$26.28 Million | ▲ +653.0% |
| 2022 | 0.38x | NT$35.82 Million | NT$94.65 Million | NT$32.91 Million | ▼ -82.4% |
| 2021 | 2.15x | NT$29.80 Million | NT$13.88 Million | NT$16.66 Million | ▲ +101.9% |
| 2020 | 1.06x | NT$78.35 Million | NT$73.66 Million | NT$38.03 Million | ▼ -95.0% |
| 2019 | 21.27x | NT$56.78 Million | NT$2.67 Million | NT$11.60 Million | — |